Covishield, Covaxin dose price may be capped at ₹425 after market nod
27.01.2022
New Delhi: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India’s drug regulator, is likely to be capped at ₹275 per dose plus an additional service charge of ₹150, official sources said.
According to them, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.
As of now, Covaxin is priced at ₹ 1,200 per dose while Covishield costs ₹ 780 in private facilities. The prices include ₹150 service charge. Both the vaccines are only authorised for emergency use in the country.
An Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation on January 19 recommended granting regular market approval to Covid vaccines Covishield and Covaxin for use in the adult population subject to certain conditions.
“The NPPA has been asked to work towards capping the price of the vaccines. The price is likely to be capped at ₹275 per dose along with an additional service charge of ₹150,” an official source said.
PTI
No comments:
Post a Comment